These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25395875)

  • 1. Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach.
    Costa DS; Aaronson NK; Fayers PM; Grimison PS; Janda M; Pallant JF; Rowen D; Velikova G; Viney R; Young TA; King MT
    Patient Relat Outcome Meas; 2014; 5():119-29. PubMed ID: 25395875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
    King MT; Costa DS; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
    Qual Life Res; 2016 Mar; 25(3):625-36. PubMed ID: 26790428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing the Breast Utility Instrument, a preference-based instrument to measure health-related quality of life in women with breast cancer: Confirmatory factor analysis of the EORTC QLQ-C30 and BR45 to establish dimensions.
    Tsui TCO; Trudeau M; Mitsakakis N; Torres S; Bremner KE; Kim D; Davis AM; Krahn MD
    PLoS One; 2022; 17(2):e0262635. PubMed ID: 35120148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer.
    Viada C; Bouza C; Fors M; Frías A; Alvarez M; García L; Wilkinson B; Rodríguez C; Crombet T; Ballesteros J
    Qual Life Res; 2020 Dec; 29(12):3441-3448. PubMed ID: 33136243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.
    Mukuria C; Rowen D; Brazier JE; Young TA; Nafees B
    Value Health; 2015 Sep; 18(6):846-55. PubMed ID: 26409613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the EORTC QLQ-BM22 Module Using Rasch Modeling and Confirmatory Factor Analysis across Countries: a Comprehensive Psychometric Evaluation in Patients with Bone Metastases.
    Lin CY; Pakpour AH
    Asian Pac J Cancer Prev; 2016; 17(3):1405-10. PubMed ID: 27039780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing the Breast Utility Instrument to Measure Health-Related Quality-of-Life Preferences in Patients with Breast Cancer: Selecting the Item for Each Dimension.
    Tsui TCO; Trudeau ME; Mitsakakis N; Krahn MD; Davis AM
    MDM Policy Pract; 2022; 7(2):23814683221142267. PubMed ID: 36532295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire.
    Shiroiwa T; King MT; Norman R; Müller F; Campbell R; Kemmler G; Murata T; Shimozuma K; Fukuda T
    Qual Life Res; 2024 Jul; 33(7):1865-1879. PubMed ID: 38724771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patients consider computer-adaptive measures more appropriate than static questionnaires?
    Gamper EM; Martini C; Petersen MA; Virgolini I; Holzner B; Giesinger JM
    J Patient Rep Outcomes; 2019 Jan; 3(1):7. PubMed ID: 30694417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies.
    Efficace F; Cottone F; Sommer K; Kieffer J; Aaronson N; Fayers P; Groenvold M; Caocci G; Lo Coco F; Gaidano G; Niscola P; Baccarani M; Rosti G; Venditti A; Angelucci E; Fazi P; Vignetti M; Giesinger J
    Value Health; 2019 Nov; 22(11):1303-1310. PubMed ID: 31708068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deriving a preference-based measure for cancer using the EORTC QLQ-C30.
    Rowen D; Brazier J; Young T; Gaugris S; Craig BM; King MT; Velikova G
    Value Health; 2011; 14(5):721-31. PubMed ID: 21839411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Chinese version of the Perceived Stress Questionnaire: development and validation amongst medical students and workers.
    Meng R; Li J; Wang Z; Zhang D; Liu B; Luo Y; Hu Y; Yu C
    Health Qual Life Outcomes; 2020 Mar; 18(1):70. PubMed ID: 32169070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
    Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
    Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROMIS-29 and EORTC QLQ-C30: an empirical investigation towards a common conception of health.
    Hartmann C; Fischer F; Klapproth CP; Röhle R; Rose M; Karsten MM
    Qual Life Res; 2023 Mar; 32(3):749-758. PubMed ID: 36617606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
    Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
    J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
    Wong CK; Lam CL; Wan YF; Rowen D
    Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life around the time of diagnosis in patients with bladder cancer.
    Yu EY; Nekeman D; Billingham LJ; James ND; Cheng KK; Bryan RT; Wesselius A; Zeegers MP
    BJU Int; 2019 Dec; 124(6):984-991. PubMed ID: 31077532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimensionality and Measurement Invariance of the Italian Version of the EORTC QLQ-C30 in Postoperative Lung Cancer Patients.
    Marzorati C; Monzani D; Mazzocco K; Pavan F; Monturano M; Pravettoni G
    Front Psychol; 2019; 10():2147. PubMed ID: 31649573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deriving the PedsUtil health state classification system to measure health utilities for pediatric populations based on the PedsQL: a confirmatory factor analysis.
    Kim DeLuca E; Dalziel K; Wittenberg E; Rose AM; Prosser LA
    Health Qual Life Outcomes; 2024 Oct; 22(1):85. PubMed ID: 39380049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
    Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
    Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.